These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6875609

  • 1. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR, Kim YI, Sanders DB.
    J Neurol Sci; 1983 Jun; 59(3):431-40. PubMed ID: 6875609
    [Abstract] [Full Text] [Related]

  • 2. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D, Namba T.
    Ann N Y Acad Sci; 1976 Jun; 274():143-73. PubMed ID: 183586
    [Abstract] [Full Text] [Related]

  • 3. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS, Kim YI, Liu HH, Johns TR.
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [Abstract] [Full Text] [Related]

  • 4. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates.
    Hohlfeld R, Sterz R, Kalies I, Peper K, Wekerle H.
    Pflugers Arch; 1981 May; 390(2):156-60. PubMed ID: 6264388
    [Abstract] [Full Text] [Related]

  • 5. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG, Tsujihata M, Lindstrom JM, Lennon VA.
    Ann N Y Acad Sci; 1976 May; 274():60-79. PubMed ID: 1066997
    [Abstract] [Full Text] [Related]

  • 6. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG, Tsujihata M, Lambert EH, Lindstrom JM, Lennon VA.
    J Neuropathol Exp Neurol; 1976 May; 35(5):569-87. PubMed ID: 956872
    [Abstract] [Full Text] [Related]

  • 7. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH, Lindstrom JM, Lennon VA.
    Ann N Y Acad Sci; 1976 May; 274():300-18. PubMed ID: 1066990
    [Abstract] [Full Text] [Related]

  • 8. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
    Fumagalli G, Engel AG, Lindstrom J.
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI, Goldner MM, Sanders DB.
    Muscle Nerve; 1980 Nov; 3(2):112-9. PubMed ID: 6245355
    [Abstract] [Full Text] [Related]

  • 11. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN, Albuquerque EX, Hudson CS, Rash JE.
    J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
    [Abstract] [Full Text] [Related]

  • 12. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M, Sakato S, Okumura S.
    J Neurol Sci; 1984 May; 66(2-3):245-53. PubMed ID: 6099402
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanisms of the synergistic interactions between organic calcium channel antagonists and various neuromuscular blocking agents.
    Chang CC, Chiou LC, Hwang LL, Huang CY.
    Jpn J Pharmacol; 1990 Jul; 53(3):285-92. PubMed ID: 2167989
    [Abstract] [Full Text] [Related]

  • 15. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ, Lambert EH, Lennon VA.
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [Abstract] [Full Text] [Related]

  • 16. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG, Sakakibara H, Sahashi K, Lindstrom JM, Lambert EH, Lennon VA.
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [Abstract] [Full Text] [Related]

  • 17. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
    Baraka A.
    Br J Anaesth; 1977 May; 49(5):479-84. PubMed ID: 861116
    [Abstract] [Full Text] [Related]

  • 18. End-plate currents and acetylcholine noise at normal and myasthenic human end-plates.
    Cull-Candy SG, Miledi R, Trautmann A.
    J Physiol; 1979 Feb; 287():247-65. PubMed ID: 430403
    [Abstract] [Full Text] [Related]

  • 19. Steroid treatment for experimental autoimmune myasthenia gravis.
    Barone DA, Lambert DH, Poser CM.
    Arch Neurol; 1980 Oct; 37(10):663-6. PubMed ID: 7425891
    [Abstract] [Full Text] [Related]

  • 20. Further observations on depolarizing neuromuscular block: the so-called phase II block.
    Galindo A, Kennedy R.
    Br J Anaesth; 1974 Jun; 46(6):405-13. PubMed ID: 4458753
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.